About us Services Therapeutic experience News Cases and webinars Contacts IPHARMA is a contract research organization specialized in conducting clinical trials of investigational drugs in the Russian Federation and the EAEU.

1. IPHARMA Clinical Services in
Russia and EAEU
IPHARMA LLC
CRO in ChemRar group

2. IPHARMA is a well-established CRO that manages clinical trials in Russia
and EAEU.
population over 183 million people
centralized healthcare system
 Partner of Skolkovo Innovative center
 Clinical division of ChemDiv Inc (USA)
 Clinical branch of ChemRar group (Russia)

3. Full cycle of clinical development from
early phase trials to registration and post-marketing PV.
QUICK FACTS 2012-2018
Innovative products in clinical
pipeline
Protocols written
Regulatory approvals
Clinical sites
Healthy volunteers enrolled
Patients enrolled
Original drugs filed for
registration
68+
80+
53+
240+
542+
8
2180+

4. THERAPEUTIC AREAS
Registration
No. Studies BE Phase I Phase II Phase III Phase IV NIS
Cardiology 5 3 1 1
Dermatology 3 2 1
Endocrinology 6 3 2 1
Gastroenterology 5 1 2 2
Neurology 7 3 2 2
Oncology 15 3 7 2 3
Otolaryngology 6 2 4
Psychiatry 4 3 1
Pulmonology 6 1 2 1 2
Rheumatology 4 3 1
Surgery 4 2 2
Urology 4 2 1 1
Virology 22 1 9 8 2 1 1
TOTAL 91 9 38 17 19 5 3

5. CLIENTS
CLIENTS: COMPANIES AND STARTUPS OF CHT "CHEMRAR"

6. GENERAL MANAGEMENT
Chief Operating Officer
MEDICAL N=11
Medical
Director
QPPV
Medical
Advisors
Medical
Associate
Assistant
CLINICAL N=30
Director of
ClinOps
Project
Managers
Senior CRA
CRA
Project
Administrators
DATA
MANAGEMENT N=5
DM Director
Programmer
Data Manager
DM Speacialist
Biostatistician
REGULATORY N=2
Director of
Regulatory
Affairs
Regulatory
Manager
QA DEPARTMENT
N=3
QA Director
Training & QA
Managers
ADMINISTRATIVE
N=3
Administrative
Director
Senior
Administrator
Office
Administrator
BD DEPARTMENT
N=5
BD Director
BD Manager
Commercial
Manager
Marketing
Manager
IPHARMA QUALIFIED STAFF (N=61)

7. Natalia Vostokova, PharmD,Chief Operating Officer
• Graduated from the Moscow Medical Academy in 2004
• In Clinical Research Since 2004 (CRA  Project Manager  Commercial
Manager  COO)
• Phase 1-3 Clinical Trials in Russia and Ukraine (Russian, US, and
European Pharma and Biotech Companies)
• 30+ Audits and 4 FDA Inspections
• Leading IPHARMA LLC since 2012
Julia Trakhtenberg, MD, PhD, Medical Director
• Graduated from the Moscow Medical Academy in 1997
• Residency and Post-Graduate Study in Endocrinology (1997 to 2006); PhD
in 2006
• In Clinical Trials since 2001 (Sub-Investigator  Medical Monitor  Medical
Director)
• Phase 1-3 Clinical Trials in Endocrinology, Ophthalmology,
Gastroenterology, Pulmonology, Hematology, Cardiovascular diseases
• Head of the Medical Department of IPHARMA since 2012

8. Oksana Karavaeva, MD,Director of Clinical Operations
• Graduated from Smolensk Medical Academy in 1998
• Residency in Endocrinology (1998 to 2001)
• In Clinical Trials Since 2001 (Medical Expert  CRA  Project Manager 
Director ClinOps)
• Phase 1-3 Trials in Neurology, Oncology, Psychiatry, Pediatrics,
Endocrinology, CV, GI, Urology, and Ophthalmology
• Head of the Clinical Department of IPHARMA since 2012
Pavel Kholkin, DM Director
• Graduated from the State University of Management in 1996 and the
Project Management Institute in 2016
• In Clinical Research Since 2015 (Data Manager  Programmer)
• Phase 1-3 Trials in Oncology, Pediatrics, Immunology and Dermatology
• Head of IPHARMA DM Department since 2018

9. Konstantin Semenov, MD, QA Director
• Graduated from the St. Petersburg Medical Academy in 1996
• Residency in Psychiatry (1996 to 1999)
• In Clinical Research Since 2000 (CRA  Auditor  QA Director)
• More than 15 Years of Clinical Trial Auditing (Clinical Sites, CRO, Labs,
Depots), Reception of Audits and FDA Inspections
• Trained in Russia and UK
• Head of IPHARMA QA Department since 2012
Diana Sapozhnikova, PhD, Director of Regulatory Affairs
• Graduated from the Moscow Medical Academy in 2003; PhD in 2006
• In Clinical Trials since 2003 (Medical Associate  Medical Director 
Regulatory Affairs)
• Phase 1-4, BE in a wide range of therapeutic areas
• Head of the Regulatory Affairs Department of IPHARMA since 2018

10. Vyacheslav Rogov, Administrative Director
• Law school of Moscow Economic and Legal University in 2010
• Over 10 years in clinical research (jurisprudence, audit, compliance)
• Member of the Ethics Committee
• Head of the Expert Group 2.2-2.4, Laboratory of program management and
projects development in the field of Living Systems
• Head of IPHARMA Administrative Department since 2017
Anna Rashina, BD Director
• Graduated from the Belgorod State University in 2005 and the State
University of Management in 2010
• In Clinical Research Since 2004 (Assistant  PM  Head of PM group 
BD Director)
• More than 12 Years as PM at Central Lab (Phase 1-4, BE, Post-Marketing
trials), 50+ Audits
• Head of IPHARMA BD Department since 2016

11. Natalia Vostokova, PharmD
Chief Operating Officer
Mobile: +7 (926) 098-36-33
NV@ipharma.ru
IPHARMA LLC (ChemRar group)
5, Nobel street, Moscow, 143026, Russia
Tel.: +7 (495) 276-11-43
Fax: +7 (495) 276-11-47
Web: www.ipharma.ru
We will be happy to conduct a complimentary feasibility for your study
and provide you with the best clinical trial solution.
Anna Rashina
Business Development Director
Mobile: +7 (903) 578-33-23
AAR@ipharma.ru